UNSPSC 51202900: Immunosupressant nucleic acids, nucleotides, and nucleosides

This classification denotes a) high-molecular-weight deoxyribose-chained or ribose-chained purine and pyrimidine nucleotide polymers, substances called nucleic acids; b) purine/pyrimidine-based monomeric units, which also contain pentose sugar and phosphate, from whence DNA/RNA polymers derive their composition, substances called nucleotides; or c) purine or pyrimidine bases bound to a deoxyribose or ribose, substances called nucleosides, all/any of which reduce a human host's humoral and/or cell-mediated defense mechanisms against deviant native cells, foreign organisms, or foreign substances (the human immune response and system thereof), thus the term IMMUNOSUPRESSANT NUCLEIC ACIDS, NUCLEOTIDES, AND NUCLEOSIDES.

UNSPSC 51202900 Immunosuppressant nucleic acids, nucleotides, and nucleosides (Class) shows limited recent activity aligned with its nominal scope. The recent opportunities tagged under this code do not reflect immunosuppressant nucleic acids or related biologics; instead, they center on emergency response supplies (naloxone and drug deactivation systems), pharmacy benefit program management and direct-to-manufacturer prescription initiatives, and generic multi-source pharmaceuticals and over-the-counter products procured through cooperative purchasing. These solicitations reflect a significant mismatch between the code's name and what state and local buyers are actually requesting under it. The code itself does not appear to drive meaningful procurement volume in the state and local market based on recent posting activity.

The issuing bodies range across county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance administering on behalf of participating states including Oregon). Recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2026, for annual delivery of 1,900 units of naloxone and 800 deactivation systems); the City of Tampa's sealed-bid solicitation for medical and first aid supplies for the Fire Department Rescue Division (ITB 26-P-00145, due March 13, 2026, estimated at $700,000.00 and sheltered for certified Small Local Business Enterprises with a 5% bid discount); Texas HHS's RFI on direct-to-manufacturer prescription programs (HHS0017013, posted April 3, 2026); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026, effective July 1, 2026). Activity centers on Florida and Texas with multistate reach through cooperative vehicles. The code does not appear to represent an active procurement focus within state and local government at present.